C42H40ClF3N12O5 — CID 167250661
6-[(6-chloro-2-methylindazol-5-yl)amino]-3-[[1-[4-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]amino]cyclooctyl]triazol-4-yl]methyl]-1-[(2,4,5-trifluorophenyl)methyl]-1,3,5-triazine-2,4-dione (PubChem CID 167250661) has the molecular formula C42H40ClF3N12O5 and a molecular weight of 885.31 g/mol. Its IUPAC name is 6-[(6-chloro-2-methylindazol-5-yl)amino]-3-[[1-[4-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]amino]cyclooctyl]triazol-4-yl]methyl]-1-[(2,4,5-trifluorophenyl)methyl]-1,3,5-triazine-2,4-dione.
| Compound Name | 6-[(6-chloro-2-methylindazol-5-yl)amino]-3-[[1-[4-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]amino]cyclooctyl]triazol-4-yl]methyl]-1-[(2,4,5-trifluorophenyl)methyl]-1,3,5-triazine-2,4-dione |
|---|---|
| PubChem CID | 167250661 |
| Molecular Formula | C42H40ClF3N12O5 |
| Molecular Weight | 885.31 g/mol |
| Exact Mass | 884.29 |
| IUPAC Name | 6-[(6-chloro-2-methylindazol-5-yl)amino]-3-[[1-[4-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]amino]cyclooctyl]triazol-4-yl]methyl]-1-[(2,4,5-trifluorophenyl)methyl]-1,3,5-triazine-2,4-dione |
| SMILES | Cn1cc2cc(Nc3nc(=O)n(Cc4cn(C5CCCCC(Nc6cccc7c6CN(C6CCC(=O)NC6=O)C7=O)CC5)nn4)c(=O)n3Cc3cc(F)c(F)cc3F)c(Cl)cc2n1 |
| InChI | InChI=1S/C42H40ClF3N12O5/c1-54-17-23-14-35(29(43)15-34(23)52-54)48-40-50-41(62)57(42(63)56(40)18-22-13-31(45)32(46)16-30(22)44)19-25-20-58(53-51-25)26-6-3-2-5-24(9-10-26)47-33-8-4-7-27-28(33)21-55(39(27)61)36-11-12-37(59)49-38(36)60/h4,7-8,13-17,20,24,26,36,47H,2-3,5-6,9-12,18-19,21H2,1H3,(H,48,50,62)(H,49,59,60) |
| InChIKey | LOSNOWGBVNPNBM-UHFFFAOYSA-N |
| XLogP | 4.93 |
| TPSA | 195.96 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 63 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 885.31 |
| LogP ≤ 5 | 4.93 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 15 |
| Structural Alerts | {'alert_name': 'halogenated_ring_1', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|